Harmsma M, Ummelen M, Dignef W, Tusenius KJ, Ramaekers FC: Effects of mistletoe (Viscum
album L.) extracts Iscador on cell cycle and survival of tumor cells. Arzneimittelforschung 2006, 56: 474–482.PubMed 88. Kelter G, Fiebig HH: Absence of tumor growth stimulation in a panel of 26 human tumor cell lines by mistletoe (Viscum album L.) extracts Iscador in vitro. Arzneimittelforschung. 2006, 56 (6A) : 435–440.PubMed 89. Maier G, Fiebig HH: Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extracts in vitro . Anti-Cancer Drugs 2002, 13: 373–379.PubMedCrossRef 90. Kahle B, Debreczeni JÉ, Sheldrick GM, Zeeck A: Vergleichende click here Zytotoxizitätsstudien von Viscotoxin-Isoformen und Röntgenstruktur von Viscotoxin A3 aus Mistelextrakten. In Fortschritte in der Misteltherapie. Aktueller Stand der Forschung und klinischen Anwendung. Edited by: Scheer R, Bauer R, Becker H, Fintelmann V, Kemper FH, Schilcher H. Essen, KVC Verlag; 2005:83–98. 91. Mukthar D, Pfüller U, Tonevitsky AG, Witthohn K, Schumacher U: Cell biological investigations on the use of mistletoe lectins in cancer therapy. In COST 98. Effects of antinutrients on the nutritional value of buy OICR-9429 legume diets. Edited by: Bardocz S, Pfüller U, Pusztai A. Luxembourg, Office for Official Publications of the European Communities; 1998:187–193.
92. Pae H-O, Seo W-G, Oh AZD2281 price G-S, Shin M-K, Lee H-S, Lee HS, Kim SB, Chung H-T: Potentiation of tumor necrosis factor-α-induced apoptosis by mistletoe lectin. Immunopharmacology and Immunotoxicology 2000, 22: 697–709.PubMedCrossRef 93. Burger AM, Mengs U, Schüler JB, Fiebig HH: Antiproliferative activity of an aqueous mistletoe extract in human tumor cell lines and xenografts in vitro. Arzneimittelforschung 2001, 51 (9) : 748–757.PubMed
94. /www.selleck.co.jp/products/MG132.html Kelter G, Schierholz JM, Fischer IU, Fiebig H-H: Cytotoxic activity and absence of tumor growth stimulation of standardized mistleteo extracts in human tumor models in vitro . Anticancer Res 2007, 27: 223–233.PubMed 95. Hugo F, Schwitalla S, Niggemann B, Zänker KS, Dittmar KEJ: Viscum album extracts Iscador ® P and Iscador ® M counteract the growth factor induced effects in human follicular B-HNL cells and breast cancer cells. Medicina 2007, 67: 90–96. 96. Beuth J, Ko HL, Schneider H, Tawadros S, Kasper HU, Zimst H, Schierholz JM: Intratumoral application of standardized mistletoe extracts down regulates tumor weight via decreased cell proliferation, increased apoptosis and necrosis in a murine model. Anticancer Res 2006, 26: 4451–4456.PubMed 97. Scheffler A, Fiebig HH, Kabelitz D, Metelmann HR: Zur direkten Zytotoxizität von Mistelpräparaten. Erfahrungsheilkunde 1993, 338–346. 98. Gabius H-J, Darro F, Remmelink M, Andre S, Kopitz J, Danguy A, Gabius S, Salmon I, Kiss R: Evidence for stimulation of tumor proliferation in cell lines and histotypic cultures by clinically relevant low doses of the galactoside-binding mistletoe lectin, a component of proprietary extracts.